Skip to content

periodontitis increases risk of thrombotic events

periodontitis increases risk of thrombotic events - PIRATE study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47154
Enrollment
100
Registered
2014-09-26
Start date
2014-11-17
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parodontitis gingivitis dental decay

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: all participants are 18 years or older cases need an indication to undergo a total tooth extraction. Indication has been made by an oral and maxillofacial surgeon controls: age, smoking- and educational status matched volunteers who respond to poster advertisements

Exclusion criteria

Exclusion criteria: inability to understand verbal and written Dutch or English language participants with (end-stage) liver disease (Child Pugh Class A, B and C) history of chronic auto immune disease (i.e. RA, vasculitis, IBD) use of antiplatelet or antithrombotic medications history of radiation in the head/neck region patients referred for focus detection in order to receive chemotherapy and/or radiotherapy for the treatment of cancer

Design outcomes

Primary

MeasureTime frame
Crossectional analysis: difference in coagulation, inflammation and metabolic markers throughout the whole cohort, with PISA as an independent variable Longitudinal analysis: difference in coagulation, inflammation and metabolic markers of patients before and after undergoing a total tooth extraction

Secondary

MeasureTime frame
Exploratory analysis of the influence of oral mircobiome on the relationships between PISA and primary outcome measures. Our focus will lie in evaluating the quantitative presence of *red complex* bacteria (see Rationale), total bacterial burden and its relationship with PISA and inflammatory/hemostatic status. The goal is to generate hypotheses for further research.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)